Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

558 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy.
Verma N, Laird JH, Moore NS, Hayman TJ, Housri N, Peters GW, Knowlton CA, Jairam V, Campbell AM, Park HS. Verma N, et al. Among authors: laird jh. Adv Radiat Oncol. 2024 Mar 21;9(6):101500. doi: 10.1016/j.adro.2024.101500. eCollection 2024 Jun. Adv Radiat Oncol. 2024. PMID: 38699671 Free PMC article.
Deep learning approach for cardiovascular disease risk stratification and survival analysis on a Canadian cohort.
Bhagawati M, Paul S, Mantella L, Johri AM, Laird JR, Singh IM, Singh R, Garg D, Fouda MM, Khanna NN, Cau R, Abraham A, Al-Maini M, Isenovic ER, Sharma AM, Fernandes JFE, Chaturvedi S, Karla MK, Nicolaides A, Saba L, Suri JS. Bhagawati M, et al. Among authors: laird jr. Int J Cardiovasc Imaging. 2024 Apr 28. doi: 10.1007/s10554-024-03100-3. Online ahead of print. Int J Cardiovasc Imaging. 2024. PMID: 38678144
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
Russell NH, Wilhelm-Benartzi C, Othman J, Dillon R, Knapper S, Batten LM, Canham J, Hinson EL, Betteridge S, Overgaard UM, Gilkes A, Potter N, Mehta P, Kottaridis P, Cavenagh J, Hemmaway C, Arnold C, Freeman SD, Dennis M; PORTEC Study Group. Russell NH, et al. J Clin Oncol. 2024 Apr 1;42(10):1158-1168. doi: 10.1200/JCO.23.00943. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215358 Clinical Trial.
Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm: A Review.
Khanna NN, Singh M, Maindarkar M, Kumar A, Johri AM, Mentella L, Laird JR, Paraskevas KI, Ruzsa Z, Singh N, Kalra MK, Fernandes JFE, Chaturvedi S, Nicolaides A, Rathore V, Singh I, Teji JS, Al-Maini M, Isenovic ER, Viswanathan V, Khanna P, Fouda MM, Saba L, Suri JS. Khanna NN, et al. Among authors: laird jr. J Korean Med Sci. 2023 Nov 27;38(46):e395. doi: 10.3346/jkms.2023.38.e395. J Korean Med Sci. 2023. PMID: 38013648 Free PMC article. Review.
558 results